NeOnc gets UAE approval for NEO100 brain cancer drug trials
Tweet Send to a Friend
NeOnc Technologies Holdings (Nasdaq: NTHI) announced that the Department of Health – Abu Dhabi has granted Investigational New Drug status ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


